Roland Broschمشاهده پروفایل
پژوهشگر
- Mycobacterial genomics
- Pathogenicity of Mycobacteria
- Evolution of Mycobacterium tuberculosis
- +۷ مورد دیگر
Roland Brosch is the Head of the Integrated Mycobacterial Pathogenomics Unit at the Institut Pasteur in Paris, France. He leads a dynamic research team focused on understanding the genomics, evolution, and pathogenicity of mycobacteria, particularly Mycobacterium tuberculosis . His work is central to uncovering the mechanisms behind the emergence of one of humanity's most persistent pathogens. His research interests span mycobacterial genomics , the evolution of M. tuberculosis from ancestral forms like M. canettii , the function of ESX secretion systems , host-pathogen interactions , and the development of novel anti-tuberculosis vaccines . His unit's work integrates cutting-edge genomic, phenotypic, and functional analyses to identify virulence factors and drug targets. The recent publications from his group, including high-impact reviews and original research in journals like PLoS Pathogens , PLoS Biology , and FEMS Microbiology Reviews , reveal a strong focus on the evolutionary trajectory of TB, the discovery of novel environmental mycobacteria as evolutionary 'missing links', the development of rapid diagnostics like TRACeR-TB, and the exploration of host-directed therapies. This indicates a research program at the forefront of both basic mycobacterial biology and translational applications. Roland Brosch is the Principal Investigator (PI) for major international research consortia, including PreDiCT-TB (focused on drug combination discovery) and TBVAC2020 (focused on next-generation TB vaccines). His unit also participates in the Labex IBEID initiative on emerging infectious diseases, highlighting the broad impact of his work. He mentors a diverse team of PhD students, postdoctoral researchers, and engineers, fostering the next generation of scientists in the field of infectious diseases. His laboratory, located at 25-28 Rue du Docteur Roux, is a hub for research on mycobacterial pathogenesis, contributing significantly to the global effort to combat tuberculosis through fundamental scientific discovery.










